AMR Action Fund said this morning that the first two beneficiaries are Adaptive Phage Therapeutics (APT ... infections through a susceptibility assay, and the approach is being tested clinically ...
University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...
University of Minnesota, Twin Cities, Minneapolis, Minnesota 55409, United States ...